20/20 Biolabs, Inc.
Visit us at booth 377
20/20 BioLabs develops and commercializes cutting-edge, AI-powered, laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases. Our advanced diagnostics leverage machine learning algorithms built on extensive real-world data, offering exceptional accuracy and convenience for individuals and providers. We pioneer affordable, accurate, and actionable tests that can be conveniently accessed at home using new upper-arm collection devices that avoid painful needles.